a2 Milk Company Limited Unsponsored ADR

a2 Milk Company Limited Unsponsored ADR

ACOPY
a2 Milk Company Limited Unsponsored ADRUS flagOther OTC
4.60
USD
-0.05
- -
3.34BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
Revenue per Share
0.16
0.17
0.24
0.51
0.77
1.27
1.78
2.35
1.62
1.94
2.17
2.32
2.62
Basic EPS, GAAP
0.01
- -
- -
0.04
0.13
0.27
0.39
0.52
0.11
0.16
0.21
0.23
0.28
Free Cash Flow per Basic Share
- -
- -
-0.02
0.03
0.14
-0.01
- -
-0.01
-0.01
-0.01
-0.01
-0.03
-0.01
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
0.09
Book Value per Share
0.1
0.09
0.1
0.2
0.32
0.6
0.99
1.51
1.61
1.77
1.81
2.06
2.25
Tangible Book Value per Share
0.08
0.05
0.07
0.17
0.32
0.75
1.06
1.52
1.44
1.46
1.42
1.59
1.82
Basic Weighted Avg Shares
589
668
634
687
716
725
733
736
742
744
733
723
724
Sales/Revenue/Turnover
94
111
155
353
549
922
1,304
1,731
1,205
1,444
1,591
1,673
1,899
Operating Margin (%)
7.68
0.16
1.18
14.89
24.69
30.43
31.68
31.37
8.87
10.8
11.39
10.03
11.53
Depreciation Expense
1
2
2
3
3
2
2
4
7
19
18
32
26
Net Income, GAAP
4
- -
-2
30
91
196
288
386
81
123
156
168
203
Effective Tax Rate (%)
20.22
98.61
263.23
41.8
34.95
30.91
30.78
29.86
32.37
36.74
35.01
35.38
33.59
Profit Margin (%)
4.37
0.01
-1.35
8.63
16.5
21.22
22.06
22.29
6.69
8.49
9.78
10.01
10.68
Working Capital
35
35
32
106
156
339
470
823
822
731
743
871
1,001
LT Debt
- -
- -
- -
- -
- -
- -
- -
13
13
80
82
61
56
Total Equity
58
52
59
133
241
556
788
1,134
1,084
1,194
1,150
1,257
1,431
Return on Invested Capital (%)
11.47
- -
-5.35
30.1
42.4
44.14
39.79
38.1
6.38
8.16
9.02
8.11
9.84
Return on Capital (%)
8.38
0.02
-3.76
31.31
49.82
59.18
49.83
41.69
6.9
9.89
11.75
12.31
13.21
Return on Common Equity (%)
8.58
0.02
-3.41
31.19
49.77
59.16
49.82
42.07
7
9.77
11.79
11.91
12.99

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
44.94%
5.04%
13.84%
Free Cash Flow
20.49%
17.97%
-80.65%
Net Income, GAAP
-113.21%
5.72%
21.07%
Sales/Revenue/Turnover
34.39%
3.66%
13.5%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
1,591
2024
- -
- -
- -
- -
1,673
2025
- -
- -
- -
- -
1,899

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.21
2024
- -
- -
- -
- -
0.23
2025
- -
- -
- -
- -
0.28

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
0.09

Company Description

APIChatGPT
CEO
David L. Bortolussi
Full Time Employees
511
Sector
Consumer Defensive
Industry
Packaged Foods
Address
51 Shortland Street Auckland AU New Zealand 1010
IPO Date
May 21, 2019
Business
The a2 Milk Company Limited (ACOPY) is a dairy nutritionals company that specializes in the research, development, production, and marketing of fresh milk and fresh milk products containing only the A2 protein type. The company offers a range of products including fresh milk, flavored milk, extended shelf life and UHT milk, infant formula products under the a2 Platinum brand, and adult nutritional products under the a2 Nutrition brand; it also provides formulations for fresh products and nutritional powders. Headquartered in Auckland, New Zealand, and founded in 2000, the company operates primarily in Australia, New Zealand, Greater China, and other international markets, targeting health-conscious consumers, parents, and individuals seeking A2 beta-casein protein alternatives to standard dairy. In recent developments within the last two years, the company has expanded its infant formula offerings in key Asian markets through strategic distribution partnerships and reported robust sales growth in its core Greater China segment amid recovering demand post-regulatory adjustments. The a2 Milk Company maintains a focus on scientific validation of A2 protein benefits, operating independently with no major parent company affiliations or recent name changes.

Company News

APIChatGPT
  • The a2 Milk Company Limited (ACOPY) Q2 2026 Earnings Call Transcript

  • The a2 Milk Company Limited (ACOPY) Shareholder/Analyst Call Transcript

  • The a2 Milk Company Limited (ACOPF) Q4 2025 Earnings Call Transcript

  • The a2 Milk Company: Multiple External And Internal Catalysts (Rating Upgrade)

  • The a2 Milk Company Limited (ACOPF) Q2 2025 Earnings Call Transcript

  • The a2 Milk Company Limited (ACOPF) Q4 2024 Earnings Call Transcript

  • The a2 Milk Company Limited (ACOPF) Q2 2024 Earnings Call Transcript